Randomized Trial of Psychotherapy for Persistently Depressed Primary Care Patients

NCT ID: NCT00541957

Last Updated: 2011-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-04-30

Study Completion Date

2010-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a pilot study. The purpose of this study is to determine whether adding 4 months of behavioral therapy to primary care physician medication treatment(relative to medication treatment alone) improves outcomes for persistently depressed primary care patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Major Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2

Medication prescribed by PCP

Group Type OTHER

Medication prescribed by PCP

Intervention Type DRUG

Can include any antidepressant medication

1

Medication prescribed by PCP + behavior therapy

Group Type EXPERIMENTAL

behavior therapy

Intervention Type BEHAVIORAL

10 sessions over 4 months

Medication prescribed by PCP

Intervention Type DRUG

Can include any antidepressant medication

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

behavior therapy

10 sessions over 4 months

Intervention Type BEHAVIORAL

Medication prescribed by PCP

Can include any antidepressant medication

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Current MDD or MDD within the past year or current dysthymia
* PHQ-9 \> 10
* have been prescribed an antidepressant medication (by their PCP) at least 8 weeks before pre-treatment timepoint
* are able to speak, read, and understand English sufficiently well to complete study procedures
* are between the ages of 18 and 70

Exclusion Criteria

* presence of significant suicidal ideation or risk
* history of bipolar disorder, schizophrenia, psychotic symptoms, or severe alcohol or drug problems within the past year;
* history of antisocial personality disorder or borderline personality disorder;
* currently in psychotherapy or have received counseling more frequently than once per month in the past year.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Memorial Hospital of Rhode Island

OTHER

Sponsor Role collaborator

Butler Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Butler Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lisa Uebelacker, PhD

Role: PRINCIPAL_INVESTIGATOR

Butler Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Memorial Hospital of RI

Pawtucket, Rhode Island, United States

Site Status

Butler Hospital

Providence, Rhode Island, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Uebelacker LA, German NM, Gaudiano BA, Miller IW. Patient health questionnaire depression scale as a suicide screening instrument in depressed primary care patients: a cross-sectional study. Prim Care Companion CNS Disord. 2011;13(1):PCC.10m01027. doi: 10.4088/PCC.10m01027.

Reference Type DERIVED
PMID: 21731830 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

K23MH067779

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment of Post-TBI Depression
NCT00211835 COMPLETED NA